Hamid O, Lewis K, Weise A, McKean M, Papadopoulos KP, Crown J, Kim TM, Lakhani NJ, Kaczmar J, Kudchadkar R, Spira A, Rabinowits G, Kim K, Carvajal R, Williamson S, Ioffe E, Chen S, Mani J, Jankovic V, Brennan L, Kroog G, Sims T, Lowy I, Gullo G. Phase 1 study of fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s179. Available from: https://jofskin.org/33014/index.php/skin/article/view/1997